SAU:4016

Middle East Pharmaceutical Industries Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 13:22 UTC

Last close

n/aSAR

Market data

23.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SAR
- computed
- Computed from the filing for 2025
22.7%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
21.1%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
17.0%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.15Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SAR
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
SAR
- computed

What it pays out is the furthest below its sector's middle: 0.35 against 0.54 on the market's range.

Follow one riyal

lens 1 of 9

After what it costs to make

62.3%

After running the business

23.5%

After interest and tax

21.1%

After what it must reinvest

17.0%

Kept after the dividend

6.8%

after what it costs to make, 62.3% of sales; after running the business, 23.5% of sales; after interest and tax, 21.1% of sales; after what it must reinvest, 17.0% of sales; kept after the dividend, 6.8% of sales

The five stops

5 of 5 read

After what it costs to make286,838,26562.3%
After running the business108,376,41823.5%
After interest and tax97,009,46521.1%
After what it must reinvest78,319,36017.0%
Kept after the dividend31,339,8436.8%

Of every unit of sales, 0.07 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales460,484,823
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
After what it costs to make286,838,265
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
After running the business108,376,418
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
After interest and tax97,009,465
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
After what it must reinvest78,319,360
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR
Kept after the dividend31,339,843
Source
computed
Statement
income
Fiscal year
2025
Reported in
SAR